Kranzler HR - Search Results

1

Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.

O'Malley SS, Corbin WR, Leeman RF, DeMartini KS, Fucito LM, Ikomi J, Romano DM, Wu R, Toll BA, Sher KJ, Gueorguieva R, Kranzler HR. O'Malley SS, et al. Among authors: kranzler hr. J Clin Psychiatry. 2015 Feb;76(2):e207-13. doi: 10.4088/JCP.13m08934. J Clin Psychiatry. 2015. PMID: 25742208 Free PMC article. Clinical Trial.

2

No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism.

Gelernter J, O'Malley S, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK. Gelernter J, et al. Among authors: kranzler hr. JAMA. 1991 Oct 2;266(13):1801-7. JAMA. 1991. PMID: 1832467

3

Carbamazepine treatment of cocaine dependence: a placebo-controlled trial.

Kranzler HR, Bauer LO, Hersh D, Klinghoffer V. Kranzler HR, et al. Drug Alcohol Depend. 1995 Jun;38(3):203-11. doi: 10.1016/0376-8716(95)01100-d. Drug Alcohol Depend. 1995. PMID: 7555620 Clinical Trial.

4

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics.

Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N. Kranzler HR, et al. Am J Psychiatry. 1995 Mar;152(3):391-7. doi: 10.1176/ajp.152.3.391. Am J Psychiatry. 1995. PMID: 7864265 Clinical Trial.

5

Buspirone treatment of anxious alcoholics. A placebo-controlled trial.

Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ. Kranzler HR, et al. Arch Gen Psychiatry. 1994 Sep;51(9):720-31. doi: 10.1001/archpsyc.1994.03950090052008. Arch Gen Psychiatry. 1994. PMID: 8080349 Clinical Trial.

6

Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.

Krystal JH, Webb E, Cooney NL, Kranzler HR, Southwick SW, Heninger GR, Charney DS. Krystal JH, et al. Among authors: kranzler hr. Am J Psychiatry. 1996 Jan;153(1):83-92. doi: 10.1176/ajp.153.1.83. Am J Psychiatry. 1996. PMID: 8540598 Clinical Trial.

7

Association of alcohol or other drug dependence with alleles of the mu opioid receptor gene (OPRM1).

Kranzler HR, Gelernter J, O'Malley S, Hernandez-Avila CA, Kaufman D. Kranzler HR, et al. Alcohol Clin Exp Res. 1998 Sep;22(6):1359-62. Alcohol Clin Exp Res. 1998. PMID: 9756053

8

Naltrexone treatment of comorbid alcohol and cocaine use disorders.

Hersh D, Van Kirk JR, Kranzler HR. Hersh D, et al. Among authors: kranzler hr. Psychopharmacology (Berl). 1998 Sep;139(1-2):44-52. doi: 10.1007/s002130050688. Psychopharmacology (Berl). 1998. PMID: 9768541 Clinical Trial.

9

Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial.

Kranzler HR, Modesto-Lowe V, Van Kirk J. Kranzler HR, et al. Neuropsychopharmacology. 2000 May;22(5):493-503. doi: 10.1016/S0893-133X(99)00135-9. Neuropsychopharmacology. 2000. PMID: 10731624 Clinical Trial.

10

Targeted naltrexone for early problem drinkers.

Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R. Kranzler HR, et al. J Clin Psychopharmacol. 2003 Jun;23(3):294-304. doi: 10.1097/01.jcp.0000084030.22282.6d. J Clin Psychopharmacol. 2003. PMID: 12826991 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

628 results

Search Page